Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 3, 2013, Pages 773-782

  Jun, Shin Hee ^a   Lee, Eun Jung ^a   Jang, Tae Sik ^a   Kim, Hyoun Ee ^a   Jang, Jun Hyeog ^b   Koh, Young Hag ^c  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROPERTIES; BONE REGENERATION; BONE TISSUE ENGINEERING; CELLULAR RESPONSE; OSTEOBLASTIC CELLS; POROUS HYDROXYAPATITE; RELEASE BEHAVIORS; THERAPEUTIC AGENTS;

BONE; CHITOSAN; COATINGS; HYDROXYAPATITE; REPAIR; SILICA GEL;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; HYDROXYAPATITE; SILICON DIOXIDE; TISSUE SCAFFOLD;

ARTICLE; BONE IMPLANT; BONE TISSUE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GEL; MATERIAL COATING; OSSIFICATION; OSTEOBLAST; POROSITY; PRIORITY JOURNAL; TISSUE ENGINEERING;

ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 2; DNA PRIMERS; DURAPATITE; MICROSCOPY, ELECTRON, SCANNING; POLYMERASE CHAIN REACTION; RABBITS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876411058     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4822-0     Document Type: Article

References (42)

1. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng. 2003;9:S5-15.
2. Silva GA, Countinho OP, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 2. Applications in bone. J Tissue Eng Reg Med. 2007; 1: 97-109.
3. Luong LN, Ramaswamy J, Kohn DH. Effects of osteogenic growth-factors on bone marrow stromal cell differentiation in a mineral-based delivery system. Biomaterials. 2012;33:283-94.
4. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog. 2009;25:1539-60.
5. Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev. 2007;59:339-59.
6. Slgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends. Macromol Bio Sci. 2004;4:743-65.
7. Liu Q. Tissue engineering. In: Shi D, editor. Biomaterials and tissue engineering. Berlin: Springer; 2004. p. 219-225.
8. Hildebrand HF, Blanchemain N, Mayer G, Chai F, Lefebvre M, Boschin F. Surface coatings for biological activation and functionalization of medical devices. Surf Coat Technol. 2006;200:6318-24.
9. Deville S, Saiz E, Tomsia AP. Freeze casting of hydroxyapatite scaffolds for bone tissue engineering. Biomaterials. 2006;27:5480-9.
10. Jansen JA, Vehof JWM, Ruhe PZ, Kroeze-Deutman H, Kuboki Y, Takita H, et al. Growth-factor loaded scaffolds for bone engineering. J Control Release. 2005;101:127-36.
11. Guda T, Walker JA, Pollot BE, Appleford MR, Ong JL, Wenke JC. In vivo performance of bilayer hydroxyapatite scaffolds for bone tissue regeneration in the rabbit radius. J Mater Sci Mater Med. 2011;22(3):647-56.
12. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26:5474-91.
13. Werner J, Linner-Krcmar B, Friess W, Greil P. Mechanical properties and in vitro cell compatibility of hydroxyapatite ceramics with graded pore structure. Biomaterials. 2002;23:4285-94.
14. Annaz B, Hing KA, Kayser M, Buckland T, Silvio LD. Porosity variation in hydroxyapatite and osteoblast morphology: a scanning electron microscopy study. J Microsc. 2004;215:100-10.
15. Appleford MR, Oh S, Oh N, Ong JL. In vivo study on hydroxyapatite scaffolds with trabecular architecture for bone repair. J Biomed Mater Res. 2009;89A:1019-27.
16. Chang BS, Lee CK, Hong KS, Youn HJ, Ryu HS, Chung SS, et al. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials. 2000;21:1291-8.
17. Abarrategi A, Garcia-Cantalejo J, Moreno-Vocente C, Civantos A, Ramos V, Casado JVS, et al. Gene expression profile on chitosan/rhBMP2 films: a novel osteoinductive coating for implantation materials. Acta Biomater. 2009;5:2633-46.
18. Tayalia P, Mooney DJ. Controlled growth factor delivery for tissue engineering. Adv Mater. 2009;21:1-17.
19. Gaalen SV, Kruyt M, Meijer G, Mistry A, Mikos A, Beucken JVD, et al. Tissue engineering of bone. In: Blitterswijk CV, Thomsen P, Williams D, Hubbell J, Cancedda R, Bruijn JD, et al., editors. editors. Tissue Engineering: United Kingdom; Elsevier Inc; 2008. p. 559-610.
20. Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M, Murata M, et al. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically reasible and nonfeasible structures: topology of osteogenesis. J Biomed Mater Res. 1998;39:190-9.
21. Bessa PC, Casal M, Reis RL. Bone morphogenic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Reg Med. 2008;2:81-96.
22. Seeherman H, Wozney JM. Delivery of bone morphogenic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev. 2005;16:329-45.
23. Jun SH, Lee EJ, Yook SW, Kim HE, Kim HW, Koh YH. A bioactive coating of a silica xerogel/chitosan hybrid on titanium by a room temperature sol-gel process. Acta Biomater. 2010;6:302-7.
24. Jun SH, Lee EJ, Kim HE, Jang JH, Koh YH. Silica-chitosan hybrid coating on Ti for controlled release of growth factors. J Mater Sci Mater Med. 2011;22:2757-64.
25. Lee EJ, Shin DS, Kim HE, Kim HW, Koh YH, Jang JH. Membrane of hybrid chitosan-silica xerogel for guided bone regeneration. Biomaterials. 2009;30:743-50.
26. Yoon BH, Koh YH, Park CS, Kim HE. Generation of large pore channels for bone tissue engineering using camphene-based freeze casting. J Am Ceram Soc. 2007;90(6):1744-52.
27. Lee EJ, Koh YH, Yoon BH, Kim HE, Kim HW. Highly porous hydroxyapatite bioceramics with interconnected pore channels using camphene-based freeze casting. Mater Lett. 2007;61:2270-3.
28. Sykarkas N, Opperman LA. Bone morphogenetic proteins: how do they function and what can they offer the clinician? J Oral Sci. 2003;45:57-73.
29. Bucholz RW, Carlton A, Holmes R. Interporous hydroxyapatite as a bone-graft substitute in tibial plateau fractures. Clin Orthop. 1989;240:53-62.
30. Zeltinger J, Sherwood JK, Graham DA, Mueller R, Griffith LG. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001;7:557-72.
31. Jeppson C, Aspenberg P. BMP-2 can inhibit bone healing. Acta Orthop Scand. 1996;67:589-92.
32. Tazaki J, Murata M, Akazawa T, Yamamoto M, Ito K, Arisue M, Shibata T, et al. BMP-2 release and dose-response studies in hydroxyapatite and b-tricalcium phosphate. Bio-Med Mater Eng. 2009;19:141-6.
33. Haidar ZS, Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett. 2009;31:1825-35.
34. Sykaras N, Opperman LA. Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J Oral Sci. 2003;45:57-73.
35. Bodde EWH, Boerman OC, Russel FGM, Mikos AG, Spauwen PHM, Jansen JA. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res. 2008;87A:780-91.
36. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R, Hubbel JA. Repair of bone defects using synthetic mimetics of collageneous extracellular matrix. Nat Biotechnol. 2003;21:513-8.
37. Ono I, Tateshita T, Inoue M, Kuboki Y. In vivo strength enhancement of hydroxyapatite combined with rhBMP-2. J Bone Miner Metal. 1998;16:81-7.
38. Kroese-Deutman HC. Quinten Ruhe P, Spauwen PHM, Jansen JA. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials. 2005;26:1131-8.
39. Raiche AT, Puleo DA. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials. 2004;25:677-85.
40. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-9.
41. Biondi M, Ungaro F, Qualia F, Netti PA. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev. 2008;60:229-42.
42. Schopper C, Moser D, Spassova-Tzekova E, Russmueller G, Goriwoda W, Lagogiannis G, et al. Mineral apposition rates provide significant information on long-term effects in BMP-induced bone regeneration. J Biomed Mater Res. 2009;89A:679-86.